# OnCo record ipss-m-ipss-r (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/ipss-m-ipss-r/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "ipss-m-ipss-r" ;
  schema:name "IPSS-R and IPSS-M (myelodysplastic syndrome risk scores)"@en ;
  schema:alternateName "IPSS"@en, "IPSS-R"@en, "IPSS-M"@en, "Revised International Prognostic Scoring System"@en, "Molecular International Prognostic Scoring System"@en, "IPSS-R score"@en, "IPSS-M score"@en, "lower-risk MDS"@en, "higher-risk MDS"@en, "very low risk MDS"@en, "very high risk MDS"@en, "MDS risk score"@en, "MDS risk group"@en ;
  schema:description "IPSS-R adds up marrow blasts, blood counts and chromosome findings, and IPSS-M adds the mutations in 31 genes, to place a person with myelodysplastic syndrome in a risk group that decides between watching, growth-factor and low-intensity drugs, or moving quickly to a transplant."@en ;
  schema:url <https://onco.cc/terms/ipss-m-ipss-r/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/terms/cytogenetics/>, <https://onco.cc/terms/tp53-mutated/>, <https://onco.cc/terms/del5q/>, <https://onco.cc/terms/sf3b1-mutation/>, <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/blasts/>, <https://onco.cc/terms/hma/>, <https://onco.cc/drugs/azacitidine/>, <https://onco.cc/drugs/luspatercept/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/imetelstat/>, <https://onco.cc/terms/allogeneic-transplant/> ;
  onco:cancers <https://onco.cc/cancers/mds-lower-risk/>, <https://onco.cc/cancers/mds-higher-risk/> .